Right ventricular (RV) and left ventricular (LV) dysfunction is common in a significant number
of hospitalized coronavirus disease 2019 (COVID-19) patients. This study was conducted to …

Background: In-hospital mortality for patients presenting with acute pulmonary embolism (PE)
has been reported to be up to 7 times higher for patients with decreased estimated …

Background Low-molecular-weight heparin (LMWH) is the treatment of choice in cancer
patients with venous thromboembolism. However, data on continuing LMWH treatment beyond …

Pulmonary hypertension (PH) is a heterogeneous group of disorders that can be classified
according to clinical, hemodynamic and pathological findings and the prognosis of each …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and serious complication
after pulmonary embolism (PE). Its incidence in the general population is around 3–30 …

Background: Treatment options for inoperable chronic thromboembolic pulmonary hypertension
(CTEPH) or persistent pulmonary hypertension after pulmonary endarterectomy (PEA) …

Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and
progressive condition; however, the true characteristics of CTEPH are still unknown, as notable …

… (D) Immunohistochemical staining with MelanA. Scale bar 800 μm. (E) Representative
photomicrograph showed MelanA immunopositivity in tumor cells. … (C and D) Pelvic CT …

… Laboratory results showed slightly elevated thrombocyte and C-reactive protein levels, as
well as high BNP and d-dimer levels (Table 1). Having scrutinized these results, a presumptive …

Background and objectives: Recurrence of venous thromboembolism (VTE) after a primary
event is common; however, no sufficient risk scores have been widely introduced in clinical …